1. New Approaches to Insomnia Management: Impact on Clinical Practice

2. Goals

3. Case Study

4. Functional Consequences of Insomnia

5. Potential Consequences of Chronic Insomnia

6. Insomnia and Quality of Life

7. Insomnia Comorbidities in the Primary Care Setting

8. DSM-5: Insomnia Disorder

9. Comorbid Psychiatric Disorders in Patients With Insomnia

11. Additional Causes of Sleep Problems

12. Hyperarousal in Patients With Insomnia

13. Assessment Tools

14. Assessment of Insomnia: Sleep History

15. Assessment of Insomnia Additional Considerations

16. Treatment Approaches Need to Treat on Several Levels

17. Nonpharmacologic Approaches

18. Pharmacologic Approaches: OTC

19. Rx Agents Used to Treat Insomnia

20. GABA Receptor Agonists

21. Advantages and Disadvantages of GABA Receptor Agonists

22. Doxepin Antidepressant and H1 Receptor Antagonist

23. Suvorexant Orexin Receptor Antagonist

24. Sedating Antidepressants Mirtazepine, Trazodone, Nefazodone, Amitriptyline, Trimipramine

25. Atypical Antipsychotics Quetiapine, Olanzapine

26. Periodic Reevaluations

27. Recommendations

28. Abbreviations

29. References

30. References (cont)

31. References (cont)

32. References (cont)

33. References (cont)

34. References (cont)

35. References (cont)

36. References (cont)

37. References (cont)

38. References (cont)

39. References (cont)